down arrow

Sanofi Consumer

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0UOS01011
  • NSEID: SANOFICONR
  • BSEID: 544250
INR
4,655.30
-18.3 (-0.39%)
BSENSE

Dec 05

BSE+NSE Vol: 1.81 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Sanofi Consumer Healthcare India Ltd stock-summary
stock-summary
Sanofi Consumer Healthcare India Ltd
Small Cap
Pharmaceuticals & Biotechnology
Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi's global strategy to establish a standalone Consumer Healthcare business. This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 23.03 Cr
Number of Shares
2.3 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
17-Jun-2024
2.3
23.03
23030622
10
Scheme of arrangement - Demerger
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 15 Schemes (13.34%)

FIIs

Held by 99 FIIs (2.94%)

Promoter with highest holding

Opella Healthcare Participations B.v. (60.4%)

Highest Public shareholder

Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund (4.62%)

Individual Investors Holdings

6.26%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchases of Stock-in-Trade
42.1
0%
 
100
Purchases of Stock-in-Trade
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
234 Cr
(Quarterly Results - Sep 2025)
Net Profit:
63 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 10,747 Cr (Small Cap)

stock-summary
P/E

50.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

1.18%

stock-summary
Debt Equity

-0.73

stock-summary
Return on Equity

83.61%

stock-summary
Price to Book

41.85

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."